Johnson & Johnson JNJ
NYSE
| 09/27/2026 | 06/28/2026 | 03/29/2026 | 12/28/2025 | 09/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.40B | 25.31B | 24.06B | 24.56B | 23.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.40B | 25.31B | 24.06B | 24.56B | 23.99B |
| Cost of Revenue | 8.10B | 8.02B | 8.09B | 7.81B | 7.29B |
| Gross Profit | 17.30B | 17.29B | 15.98B | 16.75B | 16.70B |
| SG&A Expenses | 6.11B | 6.25B | 5.85B | 6.61B | 5.78B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.86B | 17.92B | 17.47B | 18.68B | 16.75B |
| Operating Income | 6.54B | 7.39B | 6.60B | 5.89B | 7.25B |
| Income Before Tax | 34.00M | 6.75B | 5.99B | 4.97B | 7.49B |
| Income Tax Expenses | -176.00M | 1.21B | 755.00M | -150.00M | 2.34B |
| Earnings from Continuing Operations | 210.00M | 5.53B | 5.24B | 5.12B | 5.15B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 210.00M | 5.53B | 5.24B | 5.12B | 5.15B |
| EBIT | 6.54B | 7.39B | 6.60B | 5.89B | 7.25B |
| EBITDA | 8.65B | 9.35B | 8.60B | 7.90B | 9.02B |
| EPS Basic | 0.09 | 2.30 | 2.17 | 2.10 | 2.14 |
| Normalized Basic EPS | 1.65 | 1.93 | 1.66 | 1.54 | 1.91 |
| EPS Diluted | 0.09 | 2.27 | 2.14 | 2.10 | 2.12 |
| Normalized Diluted EPS | 1.63 | 1.90 | 1.64 | 1.54 | 1.89 |
| Average Basic Shares Outstanding | 2.41B | 2.41B | 2.41B | 2.44B | 2.41B |
| Average Diluted Shares Outstanding | 2.45B | 2.44B | 2.45B | 2.44B | 2.43B |
| Dividend Per Share | 1.34 | 1.34 | 1.30 | 1.30 | 1.30 |
| Payout Ratio | 1,536.67% | 58.31% | 59.81% | 61.20% | 60.79% |